(Q39155158)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28246180%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

title

TGF-β Family Signaling in Tumor Suppression and Cancer Progression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28246180%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28246180%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Roger Gomis

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28246180%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

author name string

Roger R Gomis

series ordinal

2

1 reference

PubMed publication ID

28246180

9 September 2017

publication date

1 December 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28246180%20AND%20SRC:MED&resulttype=core&format=json

Cold Spring Harbor Perspectives in Biology

4 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28246180%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28246180%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28246180%20AND%20SRC:MED&resulttype=core&format=json

Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease.

4 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

TGF-beta 1 attenuates the acquisition and expression of effector function by tumor antigen-specific human memory CD8 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Molecular characterization of the tumor microenvironment in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

TGF-β Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

A Smad action turnover switch operated by WW domain readers of a phosphoserine code

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

HER2 silences tumor suppression in breast cancer cells by switching expression of C/EBPß isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Novel activin receptors: distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Tumor-stroma interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Stromal gene expression defines poor-prognosis subtypes in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Temporal and distinct TGFbeta ligand requirements during mouse and avian endocardial cushion morphogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

CDK inhibitors (p16/p19/p21) induce senescence and autophagy in cancer-associated fibroblasts, "fueling" tumor growth via paracrine interactions, without an increase in neo-angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Autophagy and senescence in cancer-associated fibroblasts metabolically supports tumor growth and metastasis via glycolysis and ketone production

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

CTGF drives autophagy, glycolysis and senescence in cancer-associated fibroblasts via HIF1 activation, metabolically promoting tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Genetics, genomics, and evolutionary biology of NKG2D ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Neuroblastoma-derived TGF-β1 modulates the chemokine receptor repertoire of human resting NK cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Expression of Smad4 and Smad7 in human thyroid follicular carcinoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Nuclear targeting of transforming growth factor-beta-activated Smad complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

HSPB1 Inhibits the Endothelial-to-Mesenchymal Transition to Suppress Pulmonary Fibrosis and Lung Tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

TGF-β Tumor Suppression through a Lethal EMT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Smad6 determines BMP-regulated invasive behaviour of breast cancer cells in a zebrafish xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Role of tissue stroma in cancer cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Mesenchymal Cancer Cell-Stroma Crosstalk Promotes Niche Activation, Epithelial Reversion, and Metastatic Colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Smad-dependent and Smad-independent pathways in TGF-beta family signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Differentiation plasticity regulated by TGF-beta family proteins in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

TGF-beta signaling in tumor suppression and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Signaling pathway cooperation in TGF-β-induced epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

CD133+ liver cancer stem cells from methionine adenosyl transferase 1A-deficient mice demonstrate resistance to transforming growth factor (TGF)-beta-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Overexpression of the TGF-beta antagonist Smad7 in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Molecular regulation of atrioventricular valvuloseptal morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Specificity and versatility in tgf-beta signaling through Smads

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

The heart in human dystrophinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Snail1 suppresses TGF-beta-induced apoptosis and is sufficient to trigger EMT in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

TGFbeta1-induced suppression of glutathione antioxidant defenses in hepatocytes: caspase-dependent post-translational and caspase-independent transcriptional regulatory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Classifying collective cancer cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

PI3K and cancer: lessons, challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Overlapping spectra of SMAD4 mutations in juvenile polyposis (JP) and JP-HHT syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-beta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

A FoxO-Smad synexpression group in human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

ID genes mediate tumor reinitiation during breast cancer lung metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Smad7 induces hepatic metastasis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Resistance to TGF-beta-induced apoptosis in regenerating hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Crystal structure of the cytoplasmic domain of the type I TGF beta receptor in complex with FKBP12

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Microsatellite instability and mutated type II transforming growth factor-beta receptor gene in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

21 January 2018

Focus on pancreas cancer

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

The role of transforming growth factor beta in glioma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

A multigenic program mediating breast cancer metastasis to bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Smad4 signalling in T cells is required for suppression of gastrointestinal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Smad6 suppresses TGF-beta-induced growth inhibition in COLO-357 pancreatic cancer cells and is overexpressed in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Natural cytotoxicity receptors and their ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Reconstruction of functionally normal and malignant human breast tissues in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

TGF-β-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Molecular mechanisms of epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Lineage analysis in the chicken inner ear shows differences in clonal dispersion for epithelial, neuronal, and mesenchymal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

TGF-β signaling in T cells: roles in lymphoid and epithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Alterations in components of the TGF-beta superfamily signaling pathways in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

TGF-beta: a master of all T cell trades

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Transforming growth factor-beta regulation of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Beta-catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

A human Mad protein acting as a BMP-regulated transcriptional activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Ubiquitin-dependent degradation of TGF-beta-activated smad2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

PARP-1 attenuates Smad-mediated transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Positive and negative regulation of type II TGF-beta receptor signal transduction by autophosphorylation on multiple serine residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Structural determinants of Smad function in TGF-β signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Interactions between cancer stem cells and their niche govern metastatic colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

TGFβ signalling in context

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

The logic of TGFbeta signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

TGFbeta signaling in growth control, cancer, and heritable disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Genes that mediate breast cancer metastasis to lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

TGF-beta-RI kinase inhibitor SD-208 reduces the development and progression of melanoma bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Tumor-derived TGF-beta mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

TGFβ and matrix-regulated epithelial to mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Non-Smad signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Metastasis to bone: causes, consequences and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Increased Malignancy of Neu-Induced Mammary Tumors Overexpressing Active Transforming Growth Factor β1

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Dipeptide species regulate p38MAPK-Smad3 signalling to maintain chronic myelogenous leukaemia stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Perspectives of TGF-β inhibition in pancreatic and hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Radiation acts on the microenvironment to affect breast carcinogenesis by distinct mechanisms that decrease cancer latency and affect tumor type

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Synexpression groups in eukaryotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Attenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Metastasis is driven by sequential elevation of H-ras and Smad2 levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instability-high colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Transforming growth factor beta-dependent sequential activation of Smad, Bim, and caspase-9 mediates physiological apoptosis in gastric epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Mice Lacking Endoglin in Macrophages Show an Impaired Immune Response

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Metastatic stem cells: sources, niches, and vital pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

TGF-beta inhibits p70 S6 kinase via protein phosphatase 2A to induce G(1) arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

TGF beta-mediated BIM expression and apoptosis are regulated through SMAD3-dependent expression of the MAPK phosphatase MKP2

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Upregulation of two BH3-only proteins, Bmf and Bim, during TGF beta-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Endothelial-to-mesenchymal transition in pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

The two faces of transforming growth factor beta in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

The activin axis in liver biology and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Active CREB1 promotes a malignant TGFβ2 autocrine loop in glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Id proteins in development, cell cycle and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Signaling pathways governing tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-beta pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Transforming growth factor beta-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Kinetic analysis of Smad nucleocytoplasmic shuttling reveals a mechanism for transforming growth factor beta-dependent nuclear accumulation of Smads

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Escaping from the TGFbeta anti-proliferative control

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Mechanisms of TGF-beta signaling from cell membrane to the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-beta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Production of gastrointestinal tumors in mice by modulating latent TGF-β1 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

TGFBR2 and BAX mononucleotide tract mutations, microsatellite instability, and prognosis in 1072 colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Molecular definition of breast tumor heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

CLIC4 regulates TGF-β-dependent myofibroblast differentiation to produce a cancer stroma

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

The consensus coding sequences of human breast and colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Repression of p15INK4b expression by Myc through association with Miz-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

TGF-β-Id1 signaling opposes Twist1 and promotes metastatic colonization via a mesenchymal-to-epithelial transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-alpha and TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Id1 cooperates with oncogenic Ras to induce metastatic mammary carcinoma by subversion of the cellular senescence response

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Smad-dependent GADD45beta expression mediates delayed activation of p38 MAP kinase by TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Molecular characterization of a type I serine-threonine kinase receptor for TGF-beta and activin in the rat pituitary tumor cell line GH3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Transforming growth factor-beta can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Identification of NOG as a specific breast cancer bone metastasis-supporting gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Extracellular control of TGFbeta signalling in vascular development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Epithelial-mesenchymal transitions in development and pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

TGF-β activation and function in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Molecular characterization of rat transforming growth factor-beta type II receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Tumor metastasis: molecular insights and evolving paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Regulation of endothelial cell plasticity by TGF-β

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Macrophages: development and tissue specialization

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Role of tyrosine phosphorylation in ligand-independent sequestration of CXCR4 in human primary monocytes-macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Excess TGF-β mediates muscle weakness associated with bone metastases in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

p21Cip1 and p27Kip1 act in synergy to alter the sensitivity of naive T cells to TGF-beta-mediated G1 arrest through modulation of IL-2 responsiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Mechanism of activation of the TGF-beta receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Structural basis of Smad2 recognition by the Smad anchor for receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Crystal Structure of a Phosphorylated Smad2

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Smad2 nucleocytoplasmic shuttling by nucleoporins CAN/Nup214 and Nup153 feeds TGFbeta signaling complexes in the cytoplasm and nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Distinct domain utilization by Smad3 and Smad4 for nucleoporin interaction and nuclear import.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

TGF-beta-induced epithelial to mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

14-3-3ζ turns TGF-β's function from tumor suppressor to metastasis promoter in breast cancer by contextual changes of Smad partners from p53 to Gli2

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Rb/E2F4 and Smad2/3 link survivin to TGF-beta-induced apoptosis and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Endothelial-to-mesenchymal transition contributes to cardiac fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Physiology of the Renal Interstitium

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Non-Smad pathways in TGF-beta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

TGFbeta1-induced activation of ATM and p53 mediates apoptosis in a Smad7-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Dual role of SnoN in mammalian tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Juvenile polyposis, hereditary hemorrhagic telangiectasia, and early onset colorectal cancer in patients with SMAD4 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Discovery of Endothelial to Mesenchymal Transition as a Source for Carcinoma-Associated Fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Myc suppression of the p21 Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A022277

Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta

21 January 2018

1 reference

12 December 2020

Transcriptional and translational regulation of inflammatory mediator production by endogenous TGF-beta in macrophages that have ingested apoptotic cells

1 reference

12 December 2020

Active TGF-beta1 correlates with myofibroblasts and malignancy in the colorectal adenoma-carcinoma sequence

1 reference

12 December 2020

Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma

1 reference

12 December 2020

Transforming growth factor-beta 1 inhibits activation of macrophage cell line RAW 264.7 for cell killing

1 reference

12 December 2020

Transforming growth factor beta1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer

1 reference

12 December 2020

Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer

1 reference

12 December 2020

Embryonic and postnatal development of the rat renal interstitium

1 reference

12 December 2020

Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion.

1 reference

12 December 2020

The TGF beta receptor activation process: an inhibitor- to substrate-binding switch

1 reference

12 December 2020

Transforming growth factor beta type I receptor kinase mutant associated with metastatic breast cancer.

1 reference

12 December 2020

High levels of transforming growth factor beta 1 correlate with disease progression in human colon cancer

1 reference

12 December 2020

TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression.

1 reference

12 December 2020

Overexpression of C/EBPbeta-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer

1 reference

12 December 2020

Modulation of the immune response by transforming growth factor beta

1 reference

12 December 2020

Transforming growth factor-beta down-regulates major histocompatibility complex class I antigen expression and increases the susceptibility of uveal melanoma cells to natural killer cell-mediated cytolysis

1 reference

12 December 2020

Spontaneous elicitation of potent antitumor immunity and eradication of established tumors by administration of DNA encoding soluble transforming growth factor-beta II receptor without active antigen-sensitization

1 reference

12 December 2020

Balancing BMP Signaling through Integrated Inputs into the Smad1 Linker

1 reference

12 December 2020

Transforming growth factor beta1 in ductal carcinoma in situ and invasive carcinomas of the breast

1 reference

12 December 2020

High levels of transforming growth factor beta 1 in patients with colorectal cancer: association with disease progression

1 reference

12 December 2020

Positive correlation of plasma transforming growth factor-beta 1 levels with tumor vascularity in hepatocellular carcinoma

1 reference

12 December 2020

Prognostic significance of transforming growth factor beta receptor II in estrogen receptor-negative breast cancer patients

1 reference

12 December 2020

Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers.

1 reference

12 December 2020

The role for transforming growth factor-beta (TGF-beta) in human cancer

1 reference

12 December 2020

Selective inhibitory effects of Smad6 on bone morphogenetic protein type I receptors

1 reference

12 December 2020

Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma

1 reference

12 December 2020

Crystal structure of a phosphorylated Smad2. Recognition of phosphoserine by the MH2 domain and insights on Smad function in TGF-beta signaling

1 reference

12 December 2020

Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas.

1 reference

12 December 2020

Monitoring tissue repair and fibrosis from a distance

1 reference

12 December 2020

Infrequent DPC4 gene mutation in esophageal cancer, gastric cancer and ulcerative colitis-associated neoplasms

1 reference

12 December 2020

Evidence that fibroblasts derive from epithelium during tissue fibrosis

1 reference

12 December 2020

USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor

1 reference

12 December 2020

Induction of macrophage suppressor activity by fibrosarcoma-derived transforming growth factor-beta 1: contrasting effects on resting and activated macrophages

1 reference

12 December 2020

Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer

1 reference

12 December 2020

Apoptosis Induced by Transforming Growth Factor- in Fetal Hepatocyte Primary Cultures

1 reference

12 December 2020

Expression of an antisense transforming growth factor-beta1 transgene reduces tumorigenicity of EMT6 mammary tumor cells.

1 reference

12 December 2020

TGF-beta induces apoptosis through Smad-mediated expression of DAP-kinase

1 reference

12 December 2020

TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction

1 reference

12 December 2020

10.1101/CSHPERSPECT.A022277

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28246180%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28246180%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

PubMed publication ID

28246180

1 reference